Personalizing therapy in an epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer using PF-00299804 and trastuzumab

J Clin Oncol. 2010 Oct 1;28(28):e507-10. doi: 10.1200/JCO.2010.29.3126. Epub 2010 Aug 2.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Disease Progression
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Precision Medicine
  • Quinazolinones / administration & dosage*
  • Trastuzumab
  • Vinblastine / administration & dosage
  • Vinblastine / analogs & derivatives
  • Vinorelbine

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Quinazolinones
  • dacomitinib
  • Vinblastine
  • Trastuzumab
  • Vinorelbine